The Lobby
Bills
Legislators
Votes
Newsletter
Directory
/
Bills
/
H.Res. 803
H.Res. 803 · 119th Congress · House
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Active
· Submitted in House
Introduced
Oct 10, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Oct 10, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Overview
Bill Text
1
Related Bills
Votes
Bill Text Versions
1
Introduced in House
Published:
October 10, 2025
USLM Available
View Text